Nectar Lifesciences, a Rs.1,625 crore pharma major from Punjab, has posted strong growth in bottom line during the fourth quarter ended March 2013.... ...
http://www.pharmabiz.com/NewsDetails.aspx?aid=75375&sid=2India Ratings & Research has affirmed Nectar Lifesciences' long-term issuer rating at 'A-' with stable outlook. The affirmation reflects the rating... ...
http://www.indian-commodity.com/corporate/india-ratings-affirms-nectar-lifesciences-long-term-issuer-rating-at-a.aspx